May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Indocyanine Green With Mitomycin C: Effect on Cytotoxicity in Human Tenon's Fibroblasts
Author Affiliations & Notes
  • A.P. Wells
    Eye Department, Wellingon School of Medicine, Wellington, New Zealand
  • R. Wallis
    Industrial Research Limited, Wellington, New Zealand
  • J.G. Crowston
    Hamilton Glaucoma Center, University California San DIego, San Diego, CA
  • G. Reeves
    Eye Department, Wellingon School of Medicine, Wellington, New Zealand
  • Footnotes
    Commercial Relationships  A.P. Wells, None; R. Wallis, Industrial Research Limited F; J.G. Crowston, None; G. Reeves, None.
  • Footnotes
    Support  Capital Vision Research Trust, Industrial Research (Wellington) Limited
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 59. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.P. Wells, R. Wallis, J.G. Crowston, G. Reeves; Indocyanine Green With Mitomycin C: Effect on Cytotoxicity in Human Tenon's Fibroblasts . Invest. Ophthalmol. Vis. Sci. 2005;46(13):59.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: The addition of indocyanine green (ICG) to mitomycin–C (MMC) may permit localization of antimetabolite during trabeculectomy. This would facilitate estimation of treatment area, recognition of accidental application to inappropriate tissues, and sponge localization. This study examined the effect of ICG on MMC–mediated inhibition of Tenon's fibroblast proliferation. Methods: Fibroblast monolayers were exposed to either MMC (0.4mg/ml in PBS) or PBS containing indocyanine green (0.065%, 0.125%, 0.250% and 0.5% in 200µl PBS) for 5 minutes. Controls were exposed for 5 minutes to MMC, PBS or culture medium containing no ICG. Following treatment, the monolayers were washed and incubated in culture medium for 24, 48, 72hr and 1 week periods. At the conclusion of each incubation period, cell number was assessed using the CyQUANT® cell proliferation assay. Results: The presence of ICG alone, at concentrations ranging from 0.0625% to 0.500%, had no effect on the rate of fibroblast proliferation. There was no significant difference in cell number between controls and monolayers exposed to all concentrations of ICG (range 32 to 34 x 10^2 (p <0.1)) up to one week post exposure. In contrast, MMC treatment resulted in a significant reduction in viable fibroblast number (8.4 ± 0.13 x 10^2) and loss of cell viability was observed. At all concentrations tested, ICG in combination with MMC did not alter fibroblast number up to 1 week compared to MMC alone (8.5 ± 0.05 and 8.4 ± 0.12 x 10^2 respectively). Conclusions: ICG had no effect on fibroblast proliferation. ICG did not potentiate or diminish the effect of mitomycin C on Tenon's capsule fibroblast proliferation.

Keywords: wound healing 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.